Vyvanse for children with ADHD

Learn How Vyvanse® Treats ADHD in Children

Patient, caregiver and healthcare provider portrayals

Learning about Attention-Deficit/Hyperactivity Disorder (ADHD) medication for children between the ages of 6 and 17? Ask your child's doctor and explore the study results below.

Vyvanse® is the #1 Prescribed Branded ADHD Medication

ADHD in children is a treatable medical disorder

Ask the doctor if Vyvanse could be right for your child. This discussion guide can help.

Talk to the doctor

Vyvanse clinical study results

Vyvanse may help increase attention and decrease impulsiveness and hyperactivity in children ages 6 to 17 with ADHD. Your child's doctor may prescribe Vyvanse as part of a total treatment program that may include counseling or other therapies.

Vyvanse® Clinical Study Results

Clinical trials

Studies in kids aged 6-12

In one study of kids with ADHD, Vyvanse demonstrated ADHD symptom control for up to 13 hours, starting 1.5 hours after taking it.*

Clinical trial chart shows that in kids with ADHD, Vyvanse® demonstrated ADHD symptom control for up to 13 hours

Individual results may vary.

  • When taken at 7AM, Vyvanse provided ADHD symptom control at 8:30 AM.
  • Vyvanse demonstrated ADHD symptom control throughout the day and into the evening – even at 8PM.

*Based on Swanson, Kotkin, Agler, M. Flynn, and Pelham Deportment Scores (SKAMP-D)

Duration of ADHD symptom control has not been studied in teens.

In another clinical study of kids with ADHD:

  • Parents reported symptom improvement in the morning, in the afternoon, and into the early evening.

Based on Conners’ Parent Rating Scale

Your child should not take Vyvanse if he or she:

  • Is taking, or has taken within the past 14 days, an anti-depression medicine called a monoamine oxidase inhibitor (MAOI).
  • Is sensitive to, allergic to, or had a reaction to other stimulant medicines.

A study in teens aged 13-17

In one study of teens with ADHD aged 13 to 17, Vyvanse was shown to improve the symptoms of ADHD in a 4-week clinical study.

  • Vyvanse was shown to improve attention and reduce the symptoms of hyperactivity and impulsivity.

Based on the ADHD Rating Scale IV (ADHD-RS-IV) Total Score

Clinical trial chart shows Vyvanse® improved attention and reduced symptoms of hyperactivity and impulsivity in teens age 13-17

Individual results may vary.

A study in children aged 6-17

Vyvanse is approved for maintenance treatment of ADHD in children between the ages of 6 and 17

A study in children with ADHD who took Vyvanse for at least 6 months and whose symptoms were well controlled evaluated the benefit of extended treatment with Vyvanse.

During the first 4 weeks of the study, children were started on a dose of Vyvanse; the dose was adjusted as needed for the next 20 weeks. After 2 weeks of observation without any changes to the dose, children were randomly placed in 1 of 2 groups: half of the children continued to take Vyvanse while the other half were switched to sugar pill.

Study results

Clinical trial chart shows Vyvanse® is approved for maintenance treatment of ADHD in children between the ages of 6 and 17

*Treatment failure, or loss of symptom control, was defined as ≥50% increase (worsening) in the ADHD Rating Scale IV (ADHD-RS-IV) Total Score and ≥2-point increase in the Clinical Global Impression-Severity (CGI-S) score compared to scores at entry into the double-blind phase.

(lisdexamfetamine dimesylate) may not be right for everyone

Your child should take Vyvanse exactly as the doctor tells him or her to take it.

Before getting started on Vyvanse, it's important to know the potential risks of treatments.

Tell the doctor if your child:

  • has heart problems or heart defects, high blood pressure, or a family history of these problems. This is important because sudden death has occurred in people with heart problems or defects taking stimulant medicines, and sudden death, stroke and heart attack have happened in adults taking stimulant medicines. Since increases in blood pressure and heart rate may occur, the doctor should regularly check these during treatment. Call the doctor right away if you have any signs of heart problems such as chest pain, shortness of breath, or fainting while taking Vyvanse
  • has mental problems, or a family history of suicide, bipolar illness, or depression. This is important because new or worsening behavior and thought problems or bipolar illness may occur. New symptoms such as seeing or hearing things that are not real, believing things that are not true, being suspicious, or having new manic symptoms may occur. Call the doctor right away if there are any new or worsening mental symptoms during treatment
  • has circulation problems in fingers and toes (peripheral vasculopathy, including Raynaud's phenomenon). Fingers or toes may feel numb, cool, painful, sensitive to temperature and/or change color from pale, to blue, to red. Call the doctor right away if any signs of unexplained wounds appear on fingers or toes while taking Vyvanse.

See additional safety information below.

Next up?

Did you know there are 5 different ways to take Vyvanse?

Want info about Vyvanse (lisdexamfetamine dimesylate) for ADHD in Adults?

Right this way